Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder

Clinical trial NCT07330648 · RECRUITING

Trial details

NCT number: NCT07330648
Sponsor: Anhui Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2025-10-10
Primary completion: 2027-01-31
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.